The role of 5-HT1B/1D receptors in the modulation of 5-hydroxytryptamine levels in the frontal cortex of the conscious guinea pig

Artigas, 1994, Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors, Arch. Gen. Psychiatry, 51, 248, 10.1001/archpsyc.1994.03950030084009 Ayd, 1957, A preliminary report on marsalid, Am. J. Psychiatry, 114, 459, 10.1176/ajp.114.5.459 Blier, 1987, Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression, J. Clin. Psychopharmacol., 7, 24S, 10.1097/00004714-198712001-00003 Blier, 1990, Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine, Synapse, 5, 120, 10.1002/syn.890050206 Craven, 1995, Response of dorsal raphe 5-HT neurones to exogenously applied 5-HT in a midbrain slice preparation, Br. J. Pharmacol., 113, 139P Crespi, 1990, In vivo evidence that 5-HT neuronal firing rate and release are not necessarily correlated with 5-HT metabolism, Neuroscience, 35, 139, 10.1016/0306-4522(90)90128-Q Davidson, 1995, Evidence that 5-HT release in rat dorsal raphe nucleus is controlled by 5-HT1A, 5-HT1B and 5-HT1D autoreceptors, Br. J. Pharmacol., 114, 1107, 10.1111/j.1476-5381.1995.tb13321.x Delay, 1952, Note concernant l'action de l'isonicotinyl-hydrazide utilisé dans le traı̂tement des états dépressifs, Ann. Méd.-Psychol., 110, 689 Delgado, 1991, Rapid serotonin depletion as a provocative challenge test for patients with major depression: relevance to antidepressant action and the neurobiology of depression, Psychopharmacol. Bull., 27, 321 De Montigny, 1984, Electrophysiologically identified serotonin receptors in the rat CNS, Neuropharmacology, 23, 1511, 10.1016/0028-3908(84)90095-9 Engel, 1986, Identity of inhibitory pre-synaptic 5-HT autoreceptors in the rat brain cortex with 5-HT1B binding sites, Naunyn-Schmiedeberg's Arch. Pharmacol., 332, 1, 10.1007/BF00633189 Fries, 1954, Mental depression in hypertensive patients treated for long periods with large doses of reserpine, New Engl. J. Med., 251, 1006, 10.1056/NEJM195412162512504 Gardier, 1992, Effects of methiothepin on changes in brain serotonin release induced by repeated administration of high doses of anoretic serotonergic drugs, Brain Res., 588, 67, 10.1016/0006-8993(92)91345-F Gurling, J., Shiliam, C., Dourish, C.T., Routledge, C., 1994. Elevation of 5-HT release in the rat by the selective 5-HT1A receptor antagonist, WAY 100635, is dependent on the phase of the light-dark cycle. In: Louilot, A., Durkia, T., Spampinato, U., Cador, M. (Eds.), Monitoring Molecules in Neuroscience, Proceedings of the 6th Int. Conference on in Vivo Methods. p. 211. Hartig, 1996, Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes, Trends Pharmacol. Sci., 17, 103, 10.1016/0165-6147(96)30002-3 Hatcher, 1995, 5-HT1D receptors mediate hypothermia in the guinea-pig, J. Psychopharmacol., 9, 234, 10.1177/026988119500900306 Hjorth, 1994, Lack of a 5-HT1A autoreceptor desensitisation following chronic citalopram treatment as determined by in vivo microdialysis, Neuropharmacology, 33, 331, 10.1016/0028-3908(94)90062-0 Hogg, 1994, Effects of fluoxetine, metitepine and GR 127935 on 5-HT efflux in the guinea-pig cortex in vivo, Br. J. Pharmacol., 112, 644P Hoyer, 1988, Species differences in the pharmacology of the terminal 5-HT autoreceptor in mammalian species, Trends Pharmacol. Sci., 10, 130, 10.1016/0165-6147(89)90159-4 Hutson, 1995, The effects of GR 127935, a putative 5-HT1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HT concentration and behaviour in the guinea-pig, Neuropharmacology, 34, 383, 10.1016/0028-3908(95)00016-Y Invernizzi, 1994, Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A autoreceptors, Eur. J. Pharmacol., 260, 243, 10.1016/0014-2999(94)90344-1 Klapwyk, 1995, An anaesthetic mask for use on guinea-pigs (Cavia porcellus) in a stereotaxic frame, Lab. Anim. Sci., 29, 407, 10.1258/002367795780740122 Kreiss, 1992, Desensitisation of 5-HT1A autoreceptors by chronic administration of 8-OH-DPAT, Neuropharmacology, 31, 1073, 10.1016/0028-3908(92)90110-B Kuhn, 1958, The treatment of depressive states with G22355 (imipramine hydrochloride), Am. J. Psychiatry, 115, 459, 10.1176/ajp.115.5.459 Lawrence, 1992, Terminal autoreceptor control of 5-HT release as measured by in vivo microdialysis in the conscious guinea-pig, J. Neurochem., 58, 142, 10.1111/j.1471-4159.1992.tb09289.x Limberger, 1992, Species differences in pre-synaptic serotonin autoreceptors: mainly 5-HT1B but possibly in addition 5-HT1D in the rat, 5-HT1D in the rabbit and guinea-pig brain cortex, Naunyn-Schmiedeberg's Arch. Pharmacol., 343, 353, 10.1007/BF00179039 Middlemiss, 1988, A pharmacological analysis of the 5-HT receptors mediating inhibition of 5-HT release in the guinea-pig frontal cortex, Eur. J. Pharmacol., 157, 101, 10.1016/0014-2999(88)90476-1 Moret, 1995, The effect of terminal 5-HT autoreceptor antagonists on 5-HT release in the guinea-pig brain, Br. J. Pharmacol., 115, 31P Moret, C., Briley, M., 1995b. Comparative study of the in vivo effects of some 5-HT antagonists on terminal 5-HT1D autoreceptors as determined by the release of 5-HT from the substantia nigra of freely moving guinea-pigs. In: Louilot, A., Durkia, T., Spampinato, U., Cador, M. (Eds.), Monitoring Molecules in Neuroscience, Proceedings of the 6th Int. Conference on in Vivo Methods. p. 197. Mundey, 1992, Identification of 5-HT1A receptors in the dorsal raphe nucleus of the guinea-pig, Neurosci. Lett., 42, 533 O'Connor, 1992, Pharmacological characterisation of 5-HT autoreceptors in rat brain slices incorporating the dorsal raphe nucleus or the suprachiasmatic nucleus, Br. J. Pharmacol., 106, 524, 10.1111/j.1476-5381.1992.tb14369.x Rapisarda, 1977, The brain of the guinea-pig in stereotaxic coordinates, Arch. Sci. Biol., 61, 1 Roberts, 1994, Effect of the selective 5-HT1D receptor antagonist, GR127935, on in vivo 5-HT release, synthesis and turnover in the guinea-pig frontal cortex, Br. J. Pharmacol., 112, 489P, 10.1111/j.1365-2125.1994.tb04389.x Roberts, 1994, The 5-HT terminal autoreceptor is a 5-HT1D receptor subtype in the guinea-pig cortex, Br. J. Pharmacol., 112, 650P Roberts, 1996, Functional characterisation of the 5-HT terminal autoreceptor in the guinea-pig brain cortex, Br. J. Pharmacol., 117, 384, 10.1111/j.1476-5381.1996.tb15203.x Scopes, D.I.C., Clitherow, J.W., Carter, M.C., Irving, W., Collington, E.W., Skingle, M., Fenuik, W., Tyers, M.B., 1994. Heterocyclic biaryl anilides as potent selective 5-HT1D antagonists, 207th ACS meeting, San Diego, CA. Sharp, 1993, Effects of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo, Naunyn-Schmiedeberg's Arch. Pharmacol., 348, 339, 10.1007/BF00171331 Shopsin, 1975, Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients, Psychopharmacol. Commun., 1, 239 Skingle, 1993, GR127935: a potent orally active 5-HT1D receptor antagonist, Br. J. Pharmacol., 110, 9P Skingle, 1993, Effect of local infusions of 8-OH-DPAT on extracellular levels of 5-HT in the anaesthetised guinea-pig, Soc. Neurosci. Abstr., 18, 46.4 Skingle, 1994, Microdialysis study investigating the effects of GR127935, a potent 5-HT1D receptor antagonist, on cortical levels of 5-HT in the guinea-pig, Br. J. Pharmacol., 112, 488P Skingle, 1995, Effects of the 5-HT1D receptor antagonist GR 127935 on extracellular levels of 5-HT in the guinea-pig frontal cortex as measured by microdialysis, Neuropharmacology, 34, 377, 10.1016/0028-3908(94)00167-Q Sleight, 1990, In vivo effects of sumatriptan (GR 43175) on extracellular levels of 5-HT in the guinea-pig, Neuropharmacology, 29, 511, 10.1016/0028-3908(90)90061-U Starkey, 1994, 5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphe nucleus, Neuropharmacology, 33, 393, 10.1016/0028-3908(94)90069-8 Watson, 1995, GR 127935 acts as a partial agonist at recombinant human 5-HT1Dα and 5-HT1Dβ, Br. J. Pharmacol., 114, 362P